Overordnede rammer og resultater Monoterapi; randomiseret dobbeltblindet placebokontrolleret Design parallelgruppe forsøg over 120 uger Forsøgspersoner
Main features and results Monotherapy; randomised double-blind placebo-controlled Design parallel-group trial for 120 weeks Subjects